Marı́a Belén Jiménez-Dı́az

Statistics

Publications

Citations

4.2K

H-Index

Active since

2002

Affiliations

GlaxoSmithKline (Spain)(Current)

Medicines for Malaria Venture

Swiss Tropical and Public Health Institute

University of Basel

Monash University

Marı́a Belén Jiménez-Dı́az is an author at GlaxoSmithKline (Spain) specializing in pharmacology, antimalarial drug development, and antimalarial agents.

ORCID

Publications per year

2002–2024

Publications

A novel multiple-stage antimalarial agent that inhibits protein synthesis

Beatriz Baragaña, Irene Hallyburton, Neil R. Norcross et al. · Nature · 2015 · 465 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria

Margaret A. Phillips, Julie Lotharius, Kennan C. Marsh et al. · Science Translational Medicine · 2015 · 375 citations

Medicine, Pharmacology, Pharmacotherapy +9

Quinolone-3-Diarylethers: A New Class of Antimalarial Drug

Aaron Nilsen, Alexis N. LaCrue, Karen L. White et al. · Science Translational Medicine · 2013 · 302 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent<i>Plasmodium falciparum</i>Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential

José M. Coterón, María Marco, Jorge Esquivias et al. · Journal of Medicinal Chemistry · 2011 · 284 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Antimalarial efficacy of MMV390048, an inhibitor of <i>Plasmodium</i> phosphatidylinositol 4-kinase

Tanya Paquet, Claire Le Manach, Diego González Cabrera et al. · Science Translational Medicine · 2017 · 272 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

1–5 of 45